Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 32
Filtrar
1.
Bioorg Med Chem Lett ; 110: 129879, 2024 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-38977106

RESUMO

In this study, we synthesized a series of seven benzimidazole derivatives incorporating the structural acidic framework of angiotensin II (Ang II) type 1 receptor (AT1R) antagonists (ARA-II) employing a three-step reaction sequence. The chemical structures were confirmed by 1H NMR, 13C NMR and mass spectral data. Through biosimulation, compounds 1-7 were identified as computational safe hits, thus, best candidates underwent ex vivo testing against two distinct mechanisms implicated in hypertension: antagonism of the Ang II type 1 receptor and the blockade of calcium channel. Molecular docking studies helped to understand at the molecular level the dual vasorelaxant effects with the recognition sites of the AT1R and the L-type calcium channel. In an in vivo spontaneously hypertensive rat model (SHR), intraperitoneally administration of compound 1 at 20 mg/kg resulted in a 25 % reduction in systolic blood pressure, demonstrating both ex vivo vasorelaxant action and in vivo antihypertensive multitarget efficacy. ©2024 Elsevier.


Assuntos
Anti-Hipertensivos , Benzimidazóis , Simulação de Acoplamento Molecular , Ratos Endogâmicos SHR , Benzimidazóis/química , Benzimidazóis/farmacologia , Benzimidazóis/síntese química , Animais , Anti-Hipertensivos/farmacologia , Anti-Hipertensivos/síntese química , Anti-Hipertensivos/química , Ratos , Relação Estrutura-Atividade , Pressão Sanguínea/efeitos dos fármacos , Hipertensão/tratamento farmacológico , Receptor Tipo 1 de Angiotensina/metabolismo , Estrutura Molecular , Bloqueadores do Receptor Tipo 1 de Angiotensina II/farmacologia , Bloqueadores do Receptor Tipo 1 de Angiotensina II/síntese química , Bloqueadores do Receptor Tipo 1 de Angiotensina II/química , Bloqueadores dos Canais de Cálcio/farmacologia , Bloqueadores dos Canais de Cálcio/síntese química , Bloqueadores dos Canais de Cálcio/química , Canais de Cálcio Tipo L/metabolismo
2.
Rev. chil. cardiol ; 43(1): 49-52, abr. 2024. ilus
Artigo em Espanhol | LILACS | ID: biblio-1559642

RESUMO

Se presenta el caso de una paciente de 77 años, en quien, durante una cirugía de resección de tumor cutáneo, se observa incidentalmente aumento de volumen cervical derecho de características dinámicas. El hallazgo corresponde a un aneurisma de la vena yugular interna derecha, diagnóstico de mayor frecuencia en población pediátrica, habitualmente de curso benigno.


A 77-year-old woman in whom, during a skin tumor resection surgery, a right cervical swelling with dynamic characteristics was observed. The finding is compatible with an aneurysm of the right internal jugular vein, more commonly obsered in children, usually with a benign course.


Assuntos
Humanos , Feminino , Idoso , Veias Jugulares/diagnóstico por imagem , Aneurisma/diagnóstico por imagem
3.
Soc Psychol Personal Sci ; 14(1): 13-25, 2023 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-36644497

RESUMO

Shyness, the tendency to be inhibited and uncomfortable in novel social situations, is a consequential personality trait, especially during adolescence. The present study examined the development of shyness from late childhood (age 10) through adolescence (age 16) using data from a large, longitudinal study of Mexican-origin youth (N = 674). Using both self- and mother-reports of shyness assessed via the Early Adolescent Temperament Questionnaire-Revised, we found moderate to high rank-order stabilities across two-year intervals and a mean-level decrease in shyness from age 10 to 16. Anxiety and depression were associated with higher initial levels of shyness, and anxiety was associated with greater decreases in shyness from age 10 to 16. Contrary to predictions, neither nativity (country of birth) nor language proficiency (English, Spanish) was associated with the development of shyness across adolescence. Thus, youth generally decline in shyness during adolescence, although there is substantial individual variability in shyness trajectories.

4.
Arch Gynecol Obstet ; 306(6): 2035-2045, 2022 12.
Artigo em Inglês | MEDLINE | ID: mdl-35997971

RESUMO

PURPOSE: This study aimed to determine the efficacy of non-hormonal therapy with citalopram vs fluoxetine for treating vasomotor syndrome (VMS) and urogenital syndrome of menopause (GSM) in Mexican women. METHODS: A parallel prospective randomized clinical trial was conducted in 91 postmenopausal women with a total score on the Menopause Rating Scale (MRS) ≥ 17 and with the clinical diagnosis of VSM and GSM. Patients were randomly assigned to receive citalopram (n = 49) or fluoxetine (n = 42). Follow-up was carried out at 3 and 6 months. RESULTS: The citalopram group experienced a significant improvement compared to the fluoxetine group in the MRS total score (p < 0.01), as well as in the psychological (p < 0.001) and somatic (p < 0.0001) domains at 3 and 6 months of follow-up. After 6 months of follow-up, the group that received citalopram decreased the relative risk (RR) to present VMS symptoms (RR = 0.30, CI 0.19-0.5, p = 0.0001), depressed mood (RR = 0.31, CI 0.15-0.6, p = 0.0002), irritability (RR = 0.40, CI 0.22-0.73, p = 0.002), anxiety (RR = 0.30, CI 0.13-0.69, p = 0.003), physical and mental exhaustion (RR = 0.35, CI 0.18-0.67, p = 0.001), sexual problems (RR = 0.18, CI 0.06-0.48, p = 0.0001), vaginal dryness (RR = 0.34, CI 0.14-0.80, p = 0.01), and urinary problems (RR = 0.36, CI 0.14-0.92, p = 0.043). CONCLUSION: We conclude that citalopram tends to improve VSM and GSM symptoms in postmenopausal Mexican women. Thus, we recommend the daily use of citalopram 20 mg. However, further studies will be required to support the results of the present work. These should include a larger number of patients and a placebo group. CLINICAL TRIAL REGISTRATION: This clinical trial was retrospectively registered by the United States National Library of Medicine in the www. CLINICALTRIALS: gov database on 04/20/2022. The given test Registration Number is NCT05346445.


Assuntos
Citalopram , Fluoxetina , Humanos , Feminino , Citalopram/uso terapêutico , Estudos Prospectivos , Pós-Menopausa/psicologia , Menopausa/psicologia , Síndrome
5.
Int J Behav Med ; 28(3): 292-298, 2021 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32632745

RESUMO

BACKGROUND: Obesity is highly prevalent around the world, including in Chile. Although various psychological factors have been previously associated with obesity, there has been less attention on the role of weight stigma as a determinant of obesity in Chile. Therefore, the primary aim of this study was to examine the direct effect of weight stigma on obesity and determine whether chronic stress and unhealthy diet mediate the relationship between weight stigma and obesity. METHODS: Faculty and staff from a Chilean university enrolled in the Chilean Study of Psychological Predictors of Obesity and Metabolic Syndrome and completed anthropometric measurements and measures of weight stigma, chronic stress, and unhealthy diet. RESULTS: Three-hundred and eighty-three participants (Mage = 45 years old; 58% female) were included in the present analysis. Structural equation model analyses demonstrated a direct effect of weight stigma on obesity, chronic stress, and unhealthy diet. However, chronic stress and unhealthy diet did not mediate the relationship between weight stigma and obesity. CONCLUSIONS: Weight stigma is an important determinant of obesity and is associated with high levels of chronic stress and unhealthy diet in Chilean adults. Our results provide further support for the multifactorial nature of obesity and can inform future interventions aimed promoting weight loss in people with overweight and obesity.

6.
Cienc. act. fís. (Talca, En línea) ; 21(2): 1-19, jul.-dic. 2020.
Artigo em Espanhol | LILACS | ID: biblio-1127594

RESUMO

El objetivo de esta investigación fue examinar las estrategias, instrumentos y criterios de evaluación auténtica que aplican los maestros de educación física en nivel primaria, en función de la planificación y la aplicación de secuencias didácticas previamente establecidas para su proceso de intervención en el aula. Participaron voluntariamente tres maestros de educación física de tres diferentes escuelas, una escuela federal, una estatal y una privada en el estado de Chihuahua, México. El trabajo de investigación se caracterizó como un estudio de casos múltiple donde los maestros participaron en un taller de evaluación auténtica y elaboraron secuencias didácticas que fueron implementadas para examinar la aplicación de estrategias e instrumentos de evaluación auténtica. El análisis cualitativo de las observaciones, cuestionarios y entrevistas sugieren que la aplicación de dichas secuencias didácticas, junto con la implementación de una evaluación auténtica, favoreció el desempeño docente y enriqueció el ambiente de aprendizaje. Las implicaciones del estudio apuntan hacia la necesidad de formalizar y sistematizar la aplicación de estrategias e instrumentos de evaluación auténtica en la educación básica, cuando estos están directamente relacionados con las secuencias didácticas y los contenidos curriculares.


The aim of this study was to examine the strategies, instruments, and criteria of authentic evaluation that physical education teachers apply at the primary level, based on the planning and application of didactic sequences previously established for an intervention process. Initially and voluntarily, three physical education teachers participated from three different schools, one federal, one state, and one private, in Chihuahua State, Mexico. The research project was characterized as a multiple case study, where teachers participated in an authentic evaluation workshop and developed didactic sequences that were implemented to examine the application of strategies and instruments of authentic evaluation. The qualitative analysis of the observations, questionnaires, and interviews suggest that the application of these didactic sequences together with the use of authentic evaluation strategies, favored teaching performance and enriched the learning environment. The implications of the study point to the need to formalize and systematize the application of authentic evaluation strategies and instruments within basic education when these are causally related to the didactic sequencesand the curriculum content.


Assuntos
Humanos , Educação Física e Treinamento , Avaliação Educacional/métodos , Ensino , Inquéritos e Questionários , Ensino Fundamental e Médio , Aprendizagem
7.
Proc (Bayl Univ Med Cent) ; 34(1): 22-27, 2020 Aug 21.
Artigo em Inglês | MEDLINE | ID: mdl-33456139

RESUMO

The aim of this cross-sectional study was to evaluate the use and application of the atherogenic index of plasma (AIP) in the prediction of cardiovascular risk factors including mixed hyperlipidemia, hypertension, hyperuricemia, and metabolic syndrome in a population of young Mexican adults. Values were obtained for metabolic parameters, such as glucose, triglycerides, cholesterol (total, high-density, low-density, and very low density), systolic and diastolic blood pressure, and uric acid. Through univariate and multivariate analysis, parametric comparisons were applied and receiver operating characteristic curves were plotted. Logistic regression analysis was used to assess the risk of hyperuricemia, hypertension, mixed hyperlipidemia, and metabolic syndrome from a high AIP. Metabolic parameters and AIP had a significant correlation, with higher rates observed with increased AIP. As a set, metabolic parameters increased with an AIP >0.21 (λ Wilks = 0.58, F(14,344) = 7.7, P < 0.0001). The area under the curve was statistically significant for prediction of hyperuricemia (0.6), mixed hyperlipidemia (0.9), hypertension (0.8), and metabolic syndrome (0.95). In conclusion, in a sample of young Mexican adults, AIP was strongly associated with cardiovascular risk factors and could serve as a useful marker for the prediction of metabolic alterations related to cardiovascular disease.

8.
Matern Child Nutr ; 16(2): e12925, 2020 04.
Artigo em Inglês | MEDLINE | ID: mdl-31849201

RESUMO

The Lulun Project, a randomized controlled trial conducted in 2015, found that one egg per day for 6 months during early complementary feeding reduced stunting by 47% and increased linear growth by 0.63 length-for-age Z (LAZ). This follow-up cohort study (Lulun Project II) aimed to test whether the growth effect remained in the egg intervention group compared with the control group after approximately 2 years. Mothers or caregivers from the Lulun Project were recontacted and recruited for this study. Enumerators collected data on socio-economic and demographic factors, 24-hr frequency of dietary intakes, morbidities, and anthropometric measures of height, weight, and head circumference using World Health Organization protocols. Statistical analyses followed the same analytical plan as Lulun Project, applying generalized linear models and regression modelling to test group differences in height-for-age z (HAZ) from LAZ at Lulun Project endline, and structural equation modelling for mediation. One hundred thirty-five mother-child dyads were included in Lulun II, with 11% losses to follow-up from endline Lulun Project. Growth faltering across all children was evident with HAZ -2.07 ± 0.91 and a stunting prevelance of 50%. Regression modelling showed no difference between egg and control groups for the HAZ outcome and other anthropometric outcomes, and significant declines in HAZ from endline Lulun Project in the egg intervention are compared with control groups. Current dietary egg intake, however, was associated with reduced growth faltering in HAZ from Lulun Project endline to Lulun Project II, independent of group assignment and through mediation, explaining 8.8% of the total effect. Findings suggest the need for a longer intervention period and ongoing nutrition support to young children during early childhood.


Assuntos
Antropometria/métodos , Estatura , Desenvolvimento Infantil , Dieta/métodos , Ovos , Transtornos do Crescimento/epidemiologia , Peso Corporal , Pré-Escolar , Equador/epidemiologia , Feminino , Seguimentos , Transtornos do Crescimento/prevenção & controle , Humanos , Estudos Longitudinais , Masculino
9.
Gac Med Mex ; 155(3): 236-242, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31219460

RESUMO

INTRODUCTION: Hyperuricemia is a risk factor for cardiovascular disease, but its impact has not been properly documented. OBJECTIVE: To assess the impact of hyperuricemia on metabolic parameters and cardiovascular risk factors (CRF) in apparently healthy Mexicans. METHOD: Cross-sectional study of 768 young adults. Association of hyperuricemia with alterations in metabolic parameters and CRF (hypertension, mixed dyslipidemia, metabolic syndrome) was sought. Log-linear and regression models were used to determine the influence of hyperuricemia. A multivariate analysis of variance was applied to observe the interaction of hyperuricemia and overweight or obesity with changes in metabolic parameters. RESULTS: Metabolic parameters were higher in patients with hyperuricemia than with normal uric acid (all < 0.05). Hyperuricemia was significantly associated with hypertension (OR=6.8, 95 % CI: 1.1-46), dyslipidemia (OR=2.5, 95% CI: 1.3-4.7) and metabolic syndrome (OR=2.3, 95% CI: 1.1-4.6). Hyperuricemia and overweight or obesity significantly predict changes in cardiovascular risk metabolic parameters (Wilks' l=0.91, F (6.175)=3.1, p=0.007). CONCLUSIONS: Hyperuricemia is significantly associated with metabolic alterations and different CRF.


INTRODUCCIÓN: La hiperuricemia es un factor de riesgo para enfermedad cardiovascular, pero su impacto no ha sido bien documentado. OBJETIVO: Evaluar el impacto de la hiperuricemia en los parámetros metabólicos y los factores de riesgo cardiovascular en mexicanos aparentemente sanos. MÉTODO: Estudio trasversal de 768 adultos jóvenes. Se buscó asociación de la hiperuricemia con alteraciones de los parámetros metabólicos y factores de riesgo cardiovascular (hipertensión, dislipidemia mixta y síndrome metabólico). Se aplicaron modelos loglineales y de regresión para determinar la influencia de la hiperuricemia. Se aplicó análisis multivariado de varianza para observar la interacción de la hiperuricemia y el sobrepeso u obesidad en los cambios de los parámetros metabólicos. RESULTADOS: Los parámetros metabólicos fueron mayores en los individuos con hiperuricemia que con ácido úrico normal (< 0.05). La hiperuricemia se asoció significativamente con hipertensión (RM = 6.8, IC 95 % = 1.1-46), dislipidemia (RM = 2.5, IC 95 % = 1.3-4.7) y síndrome metabólico (RM = 2.3, IC 95 % = 1.1-4.6). La hiperuricemia y el sobrepeso u obesidad predicen significativamente los cambios en los parámetros metabólicos de riesgo cardiovascular (l de Wilks = 0.91, F [6.175] = 3.1, p = 0.007). CONCLUSIONES: La hiperuricemia está asociada significativamente con las alteraciones metabólicas y los distintos factores de riesgo cardiovascular.


Assuntos
Doenças Cardiovasculares/etiologia , Dislipidemias/epidemiologia , Hipertensão/epidemiologia , Hiperuricemia/complicações , Síndrome Metabólica/epidemiologia , Adolescente , Doenças Cardiovasculares/epidemiologia , Estudos Transversais , Dislipidemias/etiologia , Feminino , Humanos , Hipertensão/etiologia , Hiperuricemia/epidemiologia , Masculino , Síndrome Metabólica/etiologia , México/epidemiologia , Obesidade/complicações , Obesidade/epidemiologia , Sobrepeso/complicações , Sobrepeso/epidemiologia , Fatores de Risco , Adulto Jovem
10.
Gac. méd. Méx ; Gac. méd. Méx;155(3): 236-242, may.-jun. 2019. tab
Artigo em Inglês, Espanhol | LILACS | ID: biblio-1286498

RESUMO

Resumen Introducción: La hiperuricemia es un factor de riesgo para enfermedad cardiovascular, pero su impacto no ha sido bien documentado. Objetivo: Evaluar el impacto de la hiperuricemia en los parámetros metabólicos y los factores de riesgo cardiovascular en mexicanos aparentemente sanos. Método: Estudio trasversal de 768 adultos jóvenes. Se buscó asociación de la hiperuricemia con alteraciones de los parámetros metabólicos y factores de riesgo cardiovascular (hipertensión, dislipidemia mixta y síndrome metabólico). Se aplicaron modelos loglineales y de regresión para determinar la influencia de la hiperuricemia. Se aplicó análisis multivariado de varianza para observar la interacción de la hiperuricemia y el sobrepeso u obesidad en los cambios de los parámetros metabólicos. Resultados: Los parámetros metabólicos fueron mayores en los individuos con hiperuricemia que con ácido úrico normal (< 0.05). La hiperuricemia se asoció significativamente con hipertensión (RM = 6.8, IC 95 % = 1.1-46), dislipidemia (RM = 2.5, IC 95 % = 1.3-4.7) y síndrome metabólico (RM = 2.3, IC 95 % = 1.1-4.6). La hiperuricemia y el sobrepeso u obesidad predicen significativamente los cambios en los parámetros metabólicos de riesgo cardiovascular (l de Wilks = 0.91, F [6.175] = 3.1, p = 0.007). Conclusiones: La hiperuricemia está asociada significativamente con las alteraciones metabólicas y los distintos factores de riesgo cardiovascular.


Abstract Introduction: Hyperuricemia is a risk factor for cardiovascular disease, but its impact has not been properly documented. Objective: To assess the impact of hyperuricemia on metabolic parameters and cardiovascular risk factors (CRF) in apparently healthy Mexicans. Method: Cross-sectional study of 768 young adults. Association of hyperuricemia with alterations in metabolic parameters and CRF (hypertension, mixed dyslipidemia, metabolic syndrome) was sought. Log-linear and regression models were used to determine the influence of hyperuricemia. A multivariate analysis of variance was applied to observe the interaction of hyperuricemia and overweight or obesity with changes in metabolic parameters. Results: Metabolic parameters were higher in patients with hyperuricemia than with normal uric acid (all < 0.05). Hyperuricemia was significantly associated with hypertension (OR=6.8, 95 % CI: 1.1-46), dyslipidemia (OR=2.5, 95% CI: 1.3-4.7) and metabolic syndrome (OR=2.3, 95% CI: 1.1-4.6). Hyperuricemia and overweight or obesity significantly predict changes in cardiovascular risk metabolic parameters (Wilks’ l=0.91, F (6.175)=3.1, p=0.007). Conclusions: Hyperuricemia is significantly associated with metabolic alterations and different CRF.


Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto Jovem , Doenças Cardiovasculares/etiologia , Síndrome Metabólica/epidemiologia , Hiperuricemia/complicações , Dislipidemias/epidemiologia , Hipertensão/epidemiologia , Doenças Cardiovasculares/epidemiologia , Estudos Transversais , Fatores de Risco , Sobrepeso/complicações , México/epidemiologia , Obesidade/complicações
11.
Arch. argent. pediatr ; 117(3): 305-308, jun. 2019. ilus, tab
Artigo em Espanhol | LILACS, BINACIS | ID: biblio-1001208

RESUMO

La úlcera vulvar aguda o úlcera de Lipschütz corresponde a una entidad poco frecuente, por lo general, subdiagnosticada. Se caracteriza por la aparición súbita o aguda de lesiones ulcerosas y dolorosas en la vulva, la vagina y/o el periné, sin antecedente de contacto sexual en niñas y adolescentes. Su etiología permanece desconocida en la mayoría de los casos, aunque se ha asociado a agentes infecciosos. Para su estudio, se deben sospechar infecciones de transmisión sexual, reacciones adversas a medicamentos, enfermedades autoinmunes e inmunosupresión. Las lesiones ulcerosas desaparecen espontáneamente, de manera habitual, sin secuelas ni recurrencias a largo plazo. Se presenta el caso de una paciente adolescente de 11 años, sin inicio de actividad sexual ni menarquia y que consultó por un cuadro prodrómico de cuatro días, seguido del desarrollo agudo de úlceras genitales. Se discuten sus causas, presentación clínica, diagnósticos diferenciales y tratamiento.


Acute vulvar ulcer or ulcer of Lipschütz corresponds to a rare disease, being usually underdiagnosed. It is characterized by a sudden or acute development of ulcerous and painful lesions in the vulva, vagina and/or perineum, without a previous history of sexual contact in girls and teenagers. Its etiology remains unknown in most cases, although they have been associated with infectious agents. Their study includes the suspicion of sexually transmitted infections, adverse drug reactions, autoimmune diseases and immunosuppression. The ulcerative lesions disappear spontaneously, usually without sequelae or recurrences in the long term. We present the case of an 11-year-old adolescent patient, without sexual initiation, or menarche and who consulted due to a four-day prodromal condition, followed by the acute development of genital ulcers. Its causes, clinical presentation, differential diagnosis and treatment are discussed.


Assuntos
Humanos , Feminino , Criança , Adolescente , Úlcera , Doenças Vaginais , Doenças da Vulva , Adolescente
12.
Arch Argent Pediatr ; 117(3): e305-e308, 2019 06 01.
Artigo em Espanhol | MEDLINE | ID: mdl-31063323

RESUMO

Acute vulvar ulcer or ulcer of Lipschütz corresponds to a rare disease, being usually underdiagnosed. It is characterized by a sudden or acute development of ulcerous and painful lesions in the vulva, vagina and/or perineum, without a previous history of sexual contact in girls and teenagers. Its etiology remains unknown in most cases, although they have been associated with infectious agents. Their study includes the suspicion of sexually transmitted infections, adverse drug reactions, autoimmune diseases and immunosuppression. The ulcerative lesions disappear spontaneously, usually without sequelae or recurrences in the long term. We present the case of an 11-year-old adolescent patient, without sexual initiation, or menarche and who consulted due to a four-day prodromal condition, followed by the acute development of genital ulcers. Its causes, clinical presentation, differential diagnosis and treatment are discussed.


La úlcera vulvar aguda o úlcera de Lipschütz corresponde a una entidad poco frecuente, por lo general, subdiagnosticada. Se caracteriza por la aparición súbita o aguda de lesiones ulcerosas y dolorosas en la vulva, la vagina y/o el periné, sin antecedente de contacto sexual en niñas y adolescentes. Su etiología permanece desconocida en la mayoría de los casos, aunque se ha asociado a agentes infecciosos. Para su estudio, se deben sospechar infecciones de transmisión sexual, reacciones adversas a medicamentos, enfermedades autoinmunes e inmunosupresión. Las lesiones ulcerosas desaparecen espontáneamente, de manera habitual, sin secuelas ni recurrencias a largo plazo. Se presenta el caso de una paciente adolescente de 11 años, sin inicio de actividad sexual ni menarquia y que consultó por un cuadro prodrómico de cuatro días, seguido del desarrollo agudo de úlceras genitales. Se discuten sus causas, presentación clínica, diagnósticos diferenciales y tratamiento.


Assuntos
Úlcera/diagnóstico , Doenças da Vulva/diagnóstico , Doença Aguda , Criança , Diagnóstico Diferencial , Feminino , Humanos , Úlcera/patologia , Doenças da Vulva/patologia
13.
Med Sci (Basel) ; 7(1)2019 Jan 03.
Artigo em Inglês | MEDLINE | ID: mdl-30609870

RESUMO

Oxidative stress is present in early postmenopause. Antioxidants, present in food, avoid or limit the damage caused by free radicals. The aim of this study was to analyze whether the consumption of vitamin A, vitamin C, and Selenium was adequate in postmenopausal women and its relationship with levels of malondialdehyde. A descriptive, cross-sectional prospective clinical study was carried out with 132 women (45⁻55 years old) in postmenopause. The body mass index (BMI) and the waist-to-hip ratio (WHR) were calculated. The participants were surveyed about their food consumption for seven days. The plasmatic concentration of malondialdehyde was quantified by the methyl-phenyl-indole method. The women were grouped according to their BMI. All groups showed similar consumption of proteins, lipids, and carbohydrates, which exceeded the daily recommended level. According to the WHR, 87% had android fat distribution. Selenium, vitamin C, and vitamin A intake were below the daily recommended/suggested levels. The greater the BMI, the higher the plasmatic concentration of malondialdehyde in the patients. It was observed an elevated caloric intake, android fat distribution, and a greater BMI was accompanied by a lower consumption of antioxidants and an increased level of malondialdehyde.

14.
Rev. cuba. med ; 56(2)abr.-jun. 2017. tab
Artigo em Espanhol | LILACS, CUMED | ID: biblio-901271

RESUMO

Introducción: la presencia de síndrome metabólico y enfermedad cardiovascular está vinculada fisiopatológicamente con el sobrepeso y obesidad. Objetivo: evaluar la utilidad y precisión del Índice cintura-talla en la valoración de riesgo y diagnóstico del síndrome metabólico y otras alteraciones cardiometabólicas. Métodos: se evaluaron a adultos jóvenes aparentemente sanos para su implementación como una prueba diagnóstica o tamiz diagnóstico de rutina en los niveles primarios de atención en salud. Se realizó un estudio transversal con una muestra de 369 adultos jóvenes con edad de 18-22 años del primer año de la licenciatura de medicina en la Benemérita Universidad Autónoma de Puebla. Se determinaron parámetros bioquímicos y antropométricos para la presencia de síndrome metabólico y otras alteraciones cardiovasculares, se calculó el Índice cintura-talla y se generaron cuartiles para proponer un punto de corte con el cual se pueda valorar el riesgo y la utilidad diagnóstica. Resultados: el Índice cintura-talla mostró ser una prueba diagnóstica bastante sensible (91 por ciento, 70 por ciento y 52 por ciento) y específica (78 por ciento, 78 por ciento, 76 por ciento) en la detección de síndrome metabólico, alteraciones cardiovasculares y aterogénicas respectivamente. Los valores predictivos muestran la probabilidad del 81 por ciento de tener síndrome metabólico si el individuo cuenta con un Índice cintura-talla elevado y una probabilidad 90 por ciento de no tener síndrome metabólico si el Índice cintura-talla es normal. Conclusiones: la precisión diagnóstica del Índice cintura-talla es muy elevada, por lo que puede usarse como un tamiz diagnóstico de síndrome metabólico o de alteraciones metabólicas en adultos jóvenes aparentemente sanos(AU)


Introduction: The presence of metabolic syndrome (MS) and cadiovascular disease (CVD) is physiopathologically linked to overweight and obesity. Objective: Evaluate the usefulness and accuracy of the waist-length index (CTI) in the assessment of risk and diagnosis of the metabolic syndrome and other cardiometabolic disorders. Methods: Apparently healthy young adults were evaluated for their implementation as a diagnostic test or screening routine at the primary levels of health care. A cross-sectional study was conducted with a sample of 369 young adults aged 18-22 years of the first year of the medical degree at the Benemérita Autonomous University of Puebla (BUAP). Biochemical and anthropometric parameters were determined for the presence of metabolic syndrome and other cardiovascular alterations, the waist-height index was calculated and quartiles were generated to propose a cut-off point with which the risk and diagnostic utility could be assessed. Results: The waist-height index showed to be a very sensitive (91 percent, 70 percent and 52 percent) and specific (78 percent, 76 percent) diagnostic test in the detection of metabolic syndrome, cardiovascular and atherogenic alterations, respectively. The predictive values showed 81 percent probability of having metabolic syndrome if the subject has a high waist-height index and 90 percent chance of not having metabolic syndrome if the waist-height index is normal. Conclusions: The diagnostic accuracy of the waist-length index is very high, so it can be used as a diagnostic screen for metabolic syndrome or metabolic alterations in apparently healthy young adults(AU)


Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Síndrome Metabólica/diagnóstico , Síndrome Metabólica/epidemiologia , Razão Cintura-Estatura , Doenças Cardiovasculares/prevenção & controle , Estudos Transversais
15.
J Biotechnol ; 240: 76-84, 2016 Dec 20.
Artigo em Inglês | MEDLINE | ID: mdl-27816654

RESUMO

In this study, we developed a transplastomic C. reinhardtii strain that accumulates anti-hypertensive peptides. Tandem repeats of VLPVP peptide were included. PCR analysis confirmed the presence of the transgene in the modified strains. After in vitro digestion of biomass of a recombinant C. reinhardtii strain the VLVPV peptide was identified and quantified by HPLC. The highest expression line produced 0.292mg of recombinant protein per mg of freeze-dried biomass. Intragastric administration of the genetically modified strain to spontaneous hypertensive rats at a dose of 30mg/kg of body weight of recombinant protein significantly reduced systolic blood pressure. At the same dose, the recombinant protein exerts an ACE-inhibitory effect. This is the first study that indicates the potential of this microalga producing an antihypertensive peptide as a dietary supplement for hypertension patients.


Assuntos
Anti-Hipertensivos/farmacologia , Chlamydomonas reinhardtii , Hipertensão/tratamento farmacológico , Oligopeptídeos/farmacologia , Proteínas Recombinantes/farmacologia , Inibidores da Enzima Conversora de Angiotensina , Animais , Pressão Sanguínea/efeitos dos fármacos , Hipertensão/fisiopatologia , Masculino , Oligopeptídeos/biossíntese , Oligopeptídeos/genética , Oligopeptídeos/isolamento & purificação , Ratos , Ratos Endogâmicos SHR , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/genética , Proteínas Recombinantes/isolamento & purificação
16.
Cogitare enferm ; 19(3): 576-581, jul.-set. 2014. tab
Artigo em Português | LILACS, BDENF - Enfermagem | ID: lil-748047

RESUMO

Este estudo teve por objetivos identificar as principais dificuldades relacionadas ao aleitamento materno e levantar as intervenções referentes ao aleitamento, demandadas pelas puérperas, atendidas em uma clínica de ginecologia e obstetrícia, de um município da região sul do Brasil. Foi realizada pesquisa descritiva longitudinal, entre maio e agosto de 2012, acompanhando 31 binômios e coletando dados, por meio de entrevistas em três momentos distintos. Na primeira consulta puerperal, 61.5% das crianças estavam em aleitamento materno exclusivo e 6.5% já haviam desmamado. Houve aumento na porcentagem de aleitamento materno exclusivo nos contatos subsequentes após 40 dias (80%) e 60 dias do parto (84%). As principais dificuldades encontradas foram o ingurgitamento mamário, a fissura, a hipogalactia referida e a necessidade da mãe em voltar ao trabalho. As intervenções realizadas durante o período de estudo contribuíram positivamente para a manutenção do aleitamento materno.


This study aimed to identify the main difficulties related to breast-feeding and to survey interventions referent to breast-feeding requested by the puerperas who were attended in a gynecology and obstetrics clinic in a municipality in the southern region of Brazil. This descriptive longitudinal study was undertaken between May and August 2012, monitoring 31 mother-child dyads and collecting data through interviews at three separate points. In the first puerperal consultation, 61.5% of the children were being exclusively breast-fed and 6.5% had already been weaned. There was an increase in the percentage of the exclusive breast-feeding in the subsequent contacts after 40 days (80%) and 60 days after birth (84%). The main difficulties found were breast engorgement, fissures, hypogalactia mentioned and the mother's need to return to work. Interventions held during the study period contributed positively to the maintenance of breast-feeding.


Este estudio tuvo las finalidades de identificar las principales dificultades acerca del amamantamiento materno y verificar las intervenciones acerca del amamantamiento, demandadas por las puérperas, en una clínica de ginecología y obstetricia, de municipio de la región sur de Brasil. Fue realizada investigación descriptiva longitudinal, entre mayo y agosto de 2012, acompañhando 31 binomios y obteniendo datos por medio de entrevistas en tres momentos distintos. En la primera consulta puerperal, 61.5% de los niños estaban siendo amamantados de modo exclusivo y 6.5% no lo hacían más. Creció el porcentaje de amamantamiento materno exclusivo en los contatos subsecuentes después de 40 días (80%) y 60 días del parto (84%). Las principales dificultades fueron la obstrucción mamaria, la fisura, la hipogalactia referida y la necesidad de la madre volver al trabajo. Las intervenciones realizadas durante el periodo de estudio contribuyeron positivamente para la manutención del amamantamiento materno.


Assuntos
Humanos , Desmame , Aleitamento Materno , Saúde Materno-Infantil , Período Pós-Parto , Leite Humano
17.
Oxid Med Cell Longev ; 2013: 240560, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23997853

RESUMO

Zinc or L-NAME administration has been shown to be protector agents, decreasing oxidative stress and cell death. However, the treatment with zinc and L-NAME by intraperitoneal injection has not been studied. The aim of our work was to study the effect of zinc and L-NAME administration on nitrosative stress and cell death. Male Wistar rats were treated with ZnCl2 (2.5 mg/kg each 24 h, for 4 days) and N-ω-nitro-L-arginine-methyl ester (L-NAME, 10 mg/kg) on the day 5 (1 hour before a common carotid-artery occlusion (CCAO)). The temporoparietal cortex and hippocampus were dissected, and zinc, nitrites, and lipoperoxidation were assayed at different times. Cell death was assayed by histopathology using hematoxylin-eosin staining and caspase-3 active by immunostaining. The subacute administration of zinc before CCAO decreases the levels of zinc, nitrites, lipoperoxidation, and cell death in the late phase of the ischemia. L-NAME administration in the rats treated with zinc showed an increase of zinc levels in the early phase and increase of zinc, nitrites, and lipoperoxidation levels, cell death by necrosis, and the apoptosis in the late phase. These results suggest that the use of these two therapeutic strategies increased the injury caused by the CCAO, unlike the alone administration of zinc.


Assuntos
Artéria Carótida Primitiva/efeitos dos fármacos , Caspase 3/metabolismo , Hipóxia-Isquemia Encefálica/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , NG-Nitroarginina Metil Éster/uso terapêutico , Óxido Nítrico/metabolismo , Zinco/metabolismo , Zinco/uso terapêutico , Animais , Masculino , Estresse Oxidativo , Ratos , Ratos Wistar
18.
Nicotine Tob Res ; 15(12): 2060-8, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23873979

RESUMO

INTRODUCTION: Injection drug use and cigarette smoking are major global health concerns. Limited data exist regarding cigarette smoking behavior and quit attempts among injection drug users (IDUs) in low- and middle-income countries to inform the development of cigarette smoking interventions. We conducted a cross-sectional study to describe cigarette smoking behavior and quit attempts among IDUs in Tijuana, Mexico. METHODS: IDUs were recruited through community outreach and administered in-person interviews. Multivariable Poisson regression models were constructed to determine prevalence ratios (PRs) for quit attempts. RESULTS: Of the 670 participants interviewed, 601 (89.7%) were current smokers. Of these, median number of cigarettes smoked daily was 10; 190 (31.6%) contemplated quitting smoking in the next 6 months; 132 (22.0%) had previously quit for ≥1 year; and 124 (20.6%) had made a recent quit attempt (lasting ≥1 day during the previous 6 months). In multivariable analysis, recent quit attempts were positively associated with average monthly income (≥3,500 pesos [US$280] vs. <1,500 pesos [US$120]; PR = 2.30; 95% CI = 1.57-3.36), smoking marijuana (PR = 1.38; 95% CI = 1.01-2.90), and smoking heroin (PR = 1.85; 95% CI = 1.23-2.78), and they were negatively associated with number of cigarettes smoked daily (PR = 0.96; 95% CI = 0.94-0.98). CONCLUSIONS: One out of 5 IDUs attempted to quit cigarette smoking during the previous 6 months. Additional research is needed to improve the understanding of the association between drug use patterns and cigarette smoking quit attempts, including the higher rate of quit attempts observed among IDUs who smoke marijuana or heroin compared with IDUs who do not smoke these substances.


Assuntos
Usuários de Drogas/estatística & dados numéricos , Abandono do Hábito de Fumar/estatística & dados numéricos , Fumar/epidemiologia , Abuso de Substâncias por Via Intravenosa/complicações , Tabagismo/epidemiologia , Adolescente , Adulto , Estudos de Coortes , Estudos Transversais , Demografia , Feminino , Comportamentos Relacionados com a Saúde , Humanos , Estudos Longitudinais , Masculino , México/epidemiologia , Pessoa de Meia-Idade , Análise Multivariada , Distribuição de Poisson , Prevalência , Prevenção do Hábito de Fumar , Tabagismo/prevenção & controle , Adulto Jovem
19.
Biomed Chromatogr ; 26(11): 1399-407, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22345050

RESUMO

In the present study a simple, fast, sensitive and robust method to quantify mirtazapine in human plasma using quetiapine as the internal standard (IS) is described. The analyte and the IS were extracted from human plasma by a simple protein precipitation with methanol and were analyzed by high-performance liquid chromatography coupled to an electrospray tandem triple quadrupole mass spectrometer (HPLC-ESI-MS/MS). Chromatography was performed isocratically on a C(18), 5 µm analytical column and the run time was 1.8 min. The lower limit of quantitation was 0.5 ng/mL and a linear calibration curve over the range 0.5-150 ng/mL was obtained, showing acceptable accuracy and precision. This analytical method was applied in a relative bioavailability study in order to compare a test mirtazapine 30 mg single-dose formulation vs a reference formulation in 31 volunteers of both sexes. The study was conducted in an open randomized two-period crossover design and with a 14 day washout period. Since the 90% confidence interval for C(max) , AUC(last) and AUC(0-inf) were within the 80-125% interval proposed by the Food and Drug Administration and ANVISA (Brazilian Health Surveillance Agency), it was concluded that mirtazapine 30 mg/dose is bioequivalent to the reference formulation, according to both the rate and extent of absorption.


Assuntos
Cromatografia Líquida de Alta Pressão/métodos , Mianserina/análogos & derivados , Espectrometria de Massas em Tandem/métodos , Adulto , Área Sob a Curva , Disponibilidade Biológica , Estudos Cross-Over , Dibenzotiazepinas/sangue , Estabilidade de Medicamentos , Feminino , Humanos , Modelos Lineares , Masculino , Mianserina/sangue , Mianserina/química , Mianserina/farmacocinética , Pessoa de Meia-Idade , Mirtazapina , Fumarato de Quetiapina , Sensibilidade e Especificidade , Espectrometria de Massas por Ionização por Electrospray/métodos
20.
J Chromatogr B Analyt Technol Biomed Life Sci ; 879(31): 3728-34, 2011 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-22074958

RESUMO

In the present study a method to quantify chlorpromazine in human plasma using cyclobenzaprine as the internal standard (IS) is described. The analyte and the IS were extracted from human plasma by a liquid-liquid extraction with diethyl ether/dichloromethane (70/30, v/v) and analyzed by an ultra performance liquid chromatography (UPLC) coupled to an electrospray tandem triple quadrupole mass spectrometer in positive mode (UPLC-ES(+)-MS/MS). Chromatography was performed isocratically on an Aquity UPLC BEH C18 1.7 µm (50 mm × 2.1 mm i.d.) operating at 40°C. The mobile phase was a mixture of 65% water+1% formic acid and 35% of acetonitrile at a flow-rate of 0.5 mL/min. The lowest concentration quantified was 0.5 ng/mL and a linear calibration curve over the range 0.5-200 ng/mL was obtained, showing intra-assay precisions from 2.4 to 5.8%, and inter-assay precisions from 3.6 to 9.9%. The intra-assay accuracies ranged from 96.9 to 102.5%, while the inter-assay accuracies ranged from 94.1 to 100.3%. This analytical method was applied in a relative bioavailability study in order to compare a test chlorpromazine 100 mg simple dose formulation versus a reference in 57 volunteers of both sexes. The study was conducted in an open randomized two-period crossover design and with a fourteen days washout period. Plasma samples were obtained over a 144-h interval. Since the 90% CI for both C(max), AUC(last) and AUC(0-inf) were within the 80-125% interval proposed by the Food and Drug Administration and ANVISA, it was concluded that chlorpromazine 100 mg/dose was bioequivalent to the reference formulation, according to both the rate and extent of absorption.


Assuntos
Clorpromazina/sangue , Cromatografia Líquida de Alta Pressão/métodos , Espectrometria de Massas por Ionização por Electrospray/métodos , Espectrometria de Massas em Tandem/métodos , Adolescente , Adulto , Amitriptilina/análogos & derivados , Área Sob a Curva , Disponibilidade Biológica , Clorpromazina/farmacocinética , Estudos Cross-Over , Estabilidade de Medicamentos , Feminino , Humanos , Limite de Detecção , Modelos Lineares , Masculino , Pessoa de Meia-Idade , Distribuição Aleatória , Reprodutibilidade dos Testes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA